Adial Pharmaceuticals, Inc - stock earnings
ADIL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.4 million USD | ? USD |
| 2023Q2 | 1.1 million USD | ? USD |
| 2023Q1 | -2.9 million USD | ? USD |
| 2022Q4 | -2.9 million USD | ? USD |
| 2022Q3 | -3.0 million USD | ? USD |
| 2022Q2 | -3.9 million USD | ? USD |
| 2022Q1 | -2.8 million USD | ? USD |
| 2021Q4 | -5.8 million USD | ? USD |
| 2021Q3 | -4.3 million USD | ? USD |
| 2021Q2 | -4.4 million USD | ? USD |
| 2021Q1 | -4.8 million USD | ? USD |
| 2020Q4 | -3.5 million USD | ? USD |
| 2020Q3 | -3.3 million USD | ? USD |
| 2020Q2 | -1.8 million USD | ? USD |
| 2020Q1 | -2.3 million USD | ? USD |
| 2019Q4 | -2.1 million USD | ? USD |
| 2019Q3 | -1.7 million USD | ? USD |
| 2019Q2 | -2.1 million USD | ? USD |
| 2019Q1 | -2.7 million USD | ? USD |
| 2018Q4 | -1.3 million USD | ? USD |
| 2018Q3 | -8.2 million USD | ? USD |
| 2018Q2 | -1.8 million USD | ? USD |
| 2018Q1 | -378950 USD | ? USD |
| 2017Q4 | -403992 USD | ? USD |
| 2017Q3 | -292626 USD | ? USD |
| 2017Q2 | -264273 USD | ? USD |
| 2017Q1 | -178565 USD | ? USD |
| 2016Q4 | -95501 USD | ? USD |
| 2016Q3 | -103412 USD | ? USD |
| 2016Q2 | -95680 USD | ? USD |
| 2015Q4 | -817993 USD | ? USD |
ADIL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.1 million USD | ? USD |
| 2022 | -12.7 million USD | ? USD |
| 2021 | -19.4 million USD | ? USD |
| 2020 | -10.9 million USD | ? USD |
| 2019 | -8.6 million USD | ? USD |
| 2018 | -11.6 million USD | ? USD |
| 2017 | -1.1 million USD | ? USD |
| 2016 | -420200 USD | ? USD |
| 2015 | -817993 USD | ? USD |
ADIL
Price: $1.82
52 week price:
Earnings Per Share: -8.98 USD
P/E Ratio: -0.14
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 498900
Market Capitalization: 2.0 million